Form 8-K - Current report:
SEC Accession No. 0001564590-20-037774
Filing Date
2020-08-06
Accepted
2020-08-06 16:19:38
Documents
4
Period of Report
2020-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K onct-8k_20200806.htm 8-K 32277
2 EX-99.1 onct-ex991_6.htm EX-99.1 359679
3 GRAPHIC gmd1jjdd2fiw000001.jpg GRAPHIC 5357
4 GRAPHIC gmd1jjdd2fiw000002.jpg GRAPHIC 3681
  Complete submission text file 0001564590-20-037774.txt   405953
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

EIN.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50549 | Film No.: 201081979
SIC: 2834 Pharmaceutical Preparations